Asthma in the Elderly: The Role of Exhaled Nitric Oxide Measurements

This study is currently recruiting participants.

Verified by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C., July 2009

First Received: July 14, 2009 No Changes Posted

Sponsor:	Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
Information provided by:	Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
ClinicalTrials.gov Identifier:	NCT00939354

Purpose

This study will investigate the importance of exhaled nitric oxide measurements in subjects with asthma age 65 and older. This group of patients has been ignored in most previous asthma studies.

Condition
Asthma

Study Type:	Observational
Study Design:	Case-Only, Prospective
Official Title:	Asthma in the Elderly: The Role of Exhaled Nitric Oxide Measurements

Resource links provided by NLM:

MedlinePlus related topics: Asthma

Drug Information available for: Nitric oxide

U.S. FDA Resources

Further study details as provided by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	30
Study Start Date:	July 2009
Estimated Study Completion Date:	June 2011
Estimated Primary Completion Date:	June 2011 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	65 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Subjects with asthma over the age of 65 who are currently followed in our practice

Criteria

Inclusion Criteria:

Subjects with asthma over the age of 65 followed in our practice, non-smokers and able to give informed consent to participate in the study

Exclusion Criteria:

Smokers, subjects of diminished mental capacity

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00939354

Contacts

Contact: Albert S Rohr, M.D.	610-527-2000	rohrcolumbo@verizon.net
Contact: Michele Columbo, M.D.	610-527-2000	rohrcolumbo@verizon.net

Locations

United States, Pennsylvania
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.	Recruiting
Bryn Mawr, Pennsylvania, United States, 19010
Contact: Albert S Rohr, M.D. 610-527-2000 rohrcolumbo@verizon.net
Contact: Michele Columbo, M.D. 610-527-2000 rohrcolumbo@verizon.net
Principal Investigator: Albert S. Rohr, M.D.
Sub-Investigator: Michele Columbo, M.D.

Sponsors and Collaborators

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.

More Information

No publications provided

Responsible Party:	Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. ( Albert S. Rohr, M.D., Principal Investigator )
Study ID Numbers:	F/N-R09-2839B
Study First Received:	July 14, 2009
Last Updated:	July 14, 2009
ClinicalTrials.gov Identifier:	NCT00939354 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.:

Asthma in subjects over the age of 65

Additional relevant MeSH terms:

Respiratory System Agents
Neurotransmitter Agents
Vasodilator Agents
Antioxidants
Bronchial Diseases
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Hypersensitivity
Lung Diseases, Obstructive
Respiratory Tract Diseases
Therapeutic Uses
Free Radical Scavengers
Endothelium-Dependent Relaxing Factors

Immune System Diseases
Asthma
Anti-Asthmatic Agents
Cardiovascular Agents
Protective Agents
Pharmacologic Actions
Nitric Oxide
Autonomic Agents
Lung Diseases
Hypersensitivity, Immediate
Peripheral Nervous System Agents
Bronchodilator Agents
Respiratory Hypersensitivity

ClinicalTrials.gov processed this record on February 08, 2010